SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.954
AS - Asia 5.595
EU - Europa 3.552
SA - Sud America 947
AF - Africa 86
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.708
SG - Singapore 2.257
CN - Cina 1.714
DE - Germania 861
BR - Brasile 814
UA - Ucraina 743
HK - Hong Kong 546
IT - Italia 452
TR - Turchia 436
GB - Regno Unito 380
VN - Vietnam 298
SE - Svezia 238
FI - Finlandia 217
RU - Federazione Russa 198
PL - Polonia 147
CA - Canada 118
MX - Messico 106
FR - Francia 72
IN - India 65
ID - Indonesia 64
AR - Argentina 54
JP - Giappone 49
NL - Olanda 49
BE - Belgio 47
ZA - Sudafrica 42
BD - Bangladesh 39
ES - Italia 35
CZ - Repubblica Ceca 33
EC - Ecuador 28
IQ - Iraq 22
LT - Lituania 17
MA - Marocco 14
PY - Paraguay 13
AT - Austria 12
IR - Iran 12
UZ - Uzbekistan 12
TW - Taiwan 11
CO - Colombia 10
IL - Israele 10
CL - Cile 9
IE - Irlanda 9
SA - Arabia Saudita 9
UY - Uruguay 9
AU - Australia 8
KE - Kenya 7
PK - Pakistan 7
PT - Portogallo 7
MY - Malesia 6
CH - Svizzera 5
EG - Egitto 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
GR - Grecia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
KR - Corea 1
LK - Sri Lanka 1
MM - Myanmar 1
NG - Nigeria 1
Totale 22.144
Salva come PNG Salva come JPEG
Città #
Singapore 1.265
Fairfield 1.044
Woodbridge 1.044
Ashburn 998
Chandler 780
Jacksonville 773
Houston 764
Ann Arbor 622
Santa Clara 594
Hong Kong 539
Beijing 528
Seattle 442
Wilmington 408
Cambridge 378
Dallas 330
Izmir 257
Nanjing 243
Munich 218
New York 195
Los Angeles 191
Boardman 179
Princeton 171
Warsaw 138
Ferrara 136
San Diego 108
The Dalles 107
Ho Chi Minh City 102
Buffalo 88
Milan 85
Mexico City 76
Shanghai 75
São Paulo 75
Nanchang 70
Shenyang 69
Dearborn 63
Bremen 62
Tianjin 59
Hanoi 57
Hebei 57
Turku 54
Hefei 52
London 51
Düsseldorf 45
San Mateo 45
Brussels 44
Jiaxing 44
Tokyo 44
Changsha 42
Jakarta 42
Toronto 39
Falkenstein 38
Falls Church 38
Brooklyn 34
Jinan 33
Montreal 33
Moscow 31
Chicago 30
Kunming 30
Frankfurt am Main 29
Addison 28
Denver 28
Norwalk 28
Redwood City 28
Brno 27
Rio de Janeiro 26
Chennai 25
Council Bluffs 25
Johannesburg 25
Belo Horizonte 24
Orem 23
Auburn Hills 22
Helsinki 22
Rome 22
San Francisco 22
Amsterdam 20
Atlanta 20
Stockholm 20
Zhengzhou 20
Boston 19
Des Moines 19
Manchester 19
Mountain View 19
Guangzhou 18
Curitiba 17
Ningbo 16
Nuremberg 16
Augusta 15
Poplar 15
Hangzhou 14
Philadelphia 14
Porto Alegre 14
Washington 14
Biên Hòa 13
Florence 13
Dong Ket 12
Haiphong 12
Mcallen 12
Orange 12
Columbus 11
Guarulhos 11
Totale 14.968
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 287
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 274
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 240
Hemostasis biomarkers in multiple sclerosis 229
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 218
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 210
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 205
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 205
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 201
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 200
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 199
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 198
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 197
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 195
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 190
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 188
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 187
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 185
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 183
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 183
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 180
Membrane binding and anticoagulant properties of protein S natural variants 180
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 180
c-myc oncogene alterations in human thyroid carcinomas. 177
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 177
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 175
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 174
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 172
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 168
Plasma levels of soluble NCAM in multiple sclerosis 167
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 165
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 163
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 162
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 161
Factor VII mutant V154G models a zymogen-like form of factor VIIa 160
Partial gene deletion in a family with factor X deficiency 160
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 159
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 158
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 158
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 158
Taqi polymorphism at the human coagulation factor XII locus (F12) 157
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 157
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 156
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 155
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 155
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 155
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 154
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 153
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 152
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 152
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 150
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 149
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 147
alpha-Thalassemia trait in the region of Ferrara. 147
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 146
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 145
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 144
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 143
Two taqI RFLPs in the human von willebrand factor gene 143
Detection and characterization of polymorphic markers in the factor-VII gene. 142
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 141
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 139
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 138
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 137
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 136
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 136
The Gly331Ser mutation in factor VII in Europe and the Middle East 135
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 135
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 135
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 133
Molecular genetics and biology of congenital hemorrhagic diseases 133
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 133
Risks factors for highly unstable response to oral anticoagulation: a case-control study 132
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 132
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 132
Clinical picture and management of congenital factor VII deficiency 131
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 131
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 131
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 131
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 130
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 130
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 129
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 128
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 127
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 126
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 126
null 125
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 123
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 122
Non-conventional therapeutic strategies for inherited disorders of hemostasis 122
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 122
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 122
null 121
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 121
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 121
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 120
Hemostasis gene expression of the internal jugular and saphenous veins 120
Modulation of thrombophilia genes by environmental factors 119
Protein S mRNA in patients with protein S deficiency 119
Molecular Characteristics of a Non-deletion α-Thalassaemia of the Po River Delta 119
Totale 15.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 962
Totale 106.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.375 0 0 0 0 0 202 118 243 58 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/20265.546 974 410 1.066 1.331 1.495 270 0 0 0 0 0 0
Totale 22.357